Skip to main content
Professional Technical IVT

cardiotoxicity

Heart damage or dysfunction caused by medications, chemicals, or other therapeutic interventions.

Full Definition

Cardiotoxicity refers to heart damage or dysfunction that results from exposure to medications, chemicals, radiation, or other therapeutic interventions. This is particularly relevant in oncology where chemotherapeutic agents, targeted therapies, and radiation can cause acute or chronic cardiac complications. Manifestations may include cardiomyopathy, heart failure, arrhythmias, pericardial disease, or coronary artery disease. Prevention and early detection through cardiovascular monitoring before, during, and after potentially cardiotoxic treatments is essential. The field of cardio-oncology specifically addresses these concerns.

Usage

Usage note: Specify the causative agent when documenting cardiotoxicity.

In Context

  • "Baseline echocardiography was performed to monitor for potential cardiotoxicity before starting chemotherapy." — cardio-oncology consultation
  • "The patient developed evidence of cardiotoxicity after six months of targeted therapy." — oncology treatment note

Also known as

cardiac toxicity

Contrasted with

cardioprotection

Don't confuse with

cardiomyopathy heart failure

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON